Загрузка...
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation
Combined antiretroviral therapy (cART) for HIV-1 dramatically slows disease progression among HIV(+) individuals. Currently, lymphoma represents the main cause of death among HIV-1-infected patients. Detection of p17 variants (vp17s) endowed with B-cell clonogenic activity in HIV-1-seropositive pati...
Сохранить в:
| Опубликовано в: : | Cancer Gene Ther |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group US
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8203498/ https://ncbi.nlm.nih.gov/pubmed/33093643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41417-020-00246-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|